arrow
G

Gursimran Kochhar

Allegheny Health Network
H指数:33
被引数:4,298

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Risk of Incident Immune-Mediated Inflammatory Diseases with Second Tumor Necrosis Factor Inhibitor Versus Alternative Biologic Therapy in Patients with Inflammatory Bowel Disease and First TNFi Exposure: A Real-World Cohort Study

炎症性肠病患者在首次TNFi暴露下,使用第二个肿瘤坏死因子抑制剂与替代生物制剂治疗新发免疫介导性炎症疾病的风险:一项真实世界队列研究

2025-12-090
OAAI
Cardiovascular Risk Factors Drive Mortality in Patients With Inflammatory Bowel Disease-A Propensity-Matched US National Database Study

心血管风险因素驱动炎症性肠病患者死亡率—一项基于倾向性匹配的美国国家数据库研究

2025-10-010
PRE
Patient-Level Dynamics of Clinical Response to Mirikizumab and Its Impact on Quality of Life: Analysis From the Vivid-1 Trial in Crohn's Disease

克罗恩病患者对Mirikizumab临床反应的个体水平动态及其对生活质量的影响:来自Vivid-1试验的分析

2025-10-010
PRE
Glucagon-Like Peptide-1 Receptor Agonist Therapy Is Associated With Decreased Risk of Recurrent Pouchitis in Obese Patients With Ulcerative Colitis and IPAA: A Propensity-Matched Cohort Study

胰高血糖素样肽-1受体激动剂治疗与肥胖性溃疡性结肠炎患者接受IPAA手术后复发性储袋炎风险降低相关:一项倾向性匹配队列研究

2025-10-010
PRE
Effectiveness of Upadacitinib in Ulcerative Colitis Patients With Prior Tofacitinib Exposure: A Systematic Review and Meta-Analysis

Upadacitinib在具有托法替布暴露史溃疡性结肠炎患者中的有效性:一项系统评价和Meta分析

2025-10-010
PRE
Endoscopic diagnosis and management of adult inflammatory bowel disease: a consensus document from the American Society for Gastrointestinal Endoscopy IBD Endoscopy Consensus Panel

内镜诊断和管理成人炎症性肠病:美国胃肠内镜学会炎症性肠病内镜共识专家组的一份共识文件

2025-02-011
PRE